Dual binding site acetylcholinesterase inhibitors: Potential new disease-modifying agents for AD

Author： Monte-Millán María   García-Palomero Esther   Valenzuela Rita   Usán Paola   Austria Celia   Muñoz-Ruiz Pilar   Rubio Laura   Dorronsoro Isabel   Martínez Ana   Medina Miguel  

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.30, Iss.1-2, 2006-02, pp. : 85-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 6, Iss. 2, 2009-04 ,pp. : 112-117

Bentham Science Publishers

Access to resources Recommend Favorite

Isolation and Characterisation of Acetylcholinesterase Inhibitors from Aquilaria subintegra for the Treatment of Alzheimer’s Disease (AD)

By  

Current Alzheimer Research, Vol. 11, Iss. 2, 2014-02 ,pp. : 206-214

Bentham Science Publishers

Access to resources Recommend Favorite

The search for disease-modifying drugs for neurodegenerative disorders

By Lenzken Silvia C   Racchi Marco   Lucchelli Adele   Govoni Stefano  

Future Neurology, Vol. 1, Iss. 1, 2006-01 ,pp. : 87-96

Future Medicine

Access to resources Recommend Favorite

Towards Disease-Modifying Treatment of Alzheimer's Disease: Drugs Targeting &bgr; -Amyloid

By  

Current Alzheimer Research, Vol. 7, Iss. 1, 2010-02 ,pp. : 40-55

Bentham Science Publishers

Access to resources Recommend Favorite

Acetylcholinesterase readthrough peptide shares sequence similarity to the 28–53 peptide sequence of the acetylcholinesterase adhesion-mediating site and competes for ligand binding in vitro

By Johnson Glynis   Moore Samuel  

Journal of Molecular Neuroscience, Vol. 31, Iss. 2, 2007-06 ,pp. : 113-125

Humana Press, Inc

Access to resources Recommend Favorite